This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Alvogen Inc., priced at $0.3031 per EA under NDC 47781018001. Its NADAC has been published 363 times since Sep 11, 2019.
FDA first approved this application on Jul 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 30 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 30 mg,CllStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Alvogen Inc.NDC
47781018001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA207388FDA Approved
7/28/2017
TE Code
AB
On Market Since
7/28/2017
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 363 times since Sep 11, 2019, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3031 per EA |
|---|---|
| All-time high | $0.4758 (Sep 11, 2019) |
| All-time low | $0.2416 (Jul 17, 2024) |
| 52-week high | $0.3250 |
| 52-week low | $0.2992 |
| Median price | $0.3250 |
| Average price | $0.3382 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 363 |
| Tracking since | Sep 11, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 30 mg,Cll market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Alvogen Inc., is $0.3031 per EA (NDC 47781018001), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 36.3%. It has been tracked across 363 weekly CMS publications since Sep 11, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Sep 11, 2019, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.4758 (Sep 11, 2019), with a median of $0.3250 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 47781018001) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMIN 30 MG TAB in shortage?
Yes — NDC 47781018001 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).